EMD-16481

Single-particle
3.3 Å
EMD-16481
3D View Gallery
Deposition: 20/01/2023
Map released: 22/02/2023
Last modified: 13/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16481
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (2 RBDs up)

EMD-16481

Single-particle
3.3 Å
EMD-16481
3D View Gallery
Deposition: 20/01/2023
Map released: 22/02/2023
Last modified: 13/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Sample: SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody

Deposition Authors: Serna Martin I , Hurdiss DL
Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants.
Du W , Janssens R, Mykytyn AZ, Li W , Drabek D, van Haperen R, Chatziandreou M, Rissmann M, van der Lee J , van Dortmondt M, Martin IS, van Kuppeveld FJM, Hurdiss DL , Haagmans BL , Grosveld F, Bosch BJ
(2023) Front Immunol , 14 , 1111385 - 1111385
PUBMED: 36895554
DOI: doi:10.3389/fimmu.2023.1111385
ISSN: 1664-3224